Sartorius | SRT3 - Loan Capital

Stock Price
219.50
Daily Change
3.40 1.57%
Monthly
-8.20%
Yearly
-4.61%
Q2 Forecast
199.57

Sartorius reported EUR3.34B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Moderna USD 603M 7M Mar/2026
Organon & Co USD 8.55B 75M Mar/2026
Revvity USD 2.63B 836K Mar/2026
Sartorius EUR 3.34B 152.8M Mar/2026
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.41B 67.1M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026